Results 161 to 170 of about 132,458 (343)
Immunologic Reaction Between Extracts of Human Urinary Gonadotropin and Anti-HCG
Melvin L. Taymor+3 more
openalex +1 more source
Gender‐affirming hormone therapy: Effect on semen quality and use of fertility preservation
Abstract Fertility preservation (FP) is a fundamental part of gender care. Gender‐affirming hormone therapy (GAHT) involves the use of drugs that could be potential risk factors for fertility. Therefore, FP is recommended before beginning the gender‐affirmation process.
Anna Chiara Conflitti+7 more
wiley +1 more source
The Approach of Fertility Physicians to Donor Sperm Treatments: A Worldwide Survey. [PDF]
Maman E+5 more
europepmc +1 more source
ABSTRACT Aim Aetiological factors affecting the phenotype of adrenarche are largely unknown. This study investigated the phenotypic variability of premature adrenarche. Methods In this cross‐sectional retrospective registry study, data on 91 mainly Caucasian children diagnosed with premature adrenarche were retrieved from patient records.
Eetu Kanniainen+2 more
wiley +1 more source
Growth hormone and gonadotropin association: A case report of full-term pregnancy in a patient with panhypopituitarism. [PDF]
Quandt L+7 more
europepmc +1 more source
Unilateral Gynecomastia and Primary Hypogonadism Following Brucellosis Infection: A Rare Case Report. [PDF]
Safdari Y.
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source